Bannermain 1

Discover what makes Lanluma special​

A revolutionary PLLA collagen stimulating injectable​
A revolutionary PLLA collagen stimulating injectable​

High product stability demonstration ***

Lanluma’s enviable safety profile

Lanluma has proven great safety and efficacy through evidence obtained from clinical data and daily practice of physicians giving you the confidence of prescribing it to your patients. If you want to know how we achieve this, download our Safety Profile file.

Download here
Web3 Min

Discover what our patients think about their Lanluma treatments

I love Lanluma because it works with your own body to create natural-looking and safe results with minimal downtime.
My clothes feel better, and I feel better. Lanluma has upped my self-confidence and I truly recommend it.
A top quality product. My patients are loving the results – long lasting and so many smiles and thank yous! My team is loving the different size options and the quick prep time. The quality and care really makes Lanluma stand out.
Felt like a bit of a pinch, but not painful at all. The results are amazing from the first session.
Lanluma has made my buttocks look fuller and I have a more defined shape. I could not be happier!

Lanluma is intended to be administrated via injection by a trained and authorized health professional. Opinions and methods presented here are the Physician experience. Refer to instructions for details of specific indications.

*J AmAcadDermatol 2010:62:448-62.

** Sinclair data on file. Evidence was gathered from treatments performed by health care professionals across Europe and the UK – February 2021 to January 2023​

***Data on file​​

NOTICE

Content regarding Lanluma® is not intended for patients and healthcare professionals based in Germany and Spain.

Die Inhalte zu Lanluma® sind nicht für Patienten und Ärzte mit Sitz in Deutschland bestimmt.

El contenido relacionado con Lanluma® no está destinado a pacientes y profesionales sanitarios con sede en España.

NOTICE

Content regarding Lanluma® is not intended for patients and healthcare professionals based in Germany and Spain.

Die Inhalte zu Lanluma® sind nicht für Patienten und Ärzte mit Sitz in Deutschland bestimmt.

El contenido relacionado con Lanluma® no está destinado a pacientes y profesionales sanitarios con sede en España.

INDICATION

Lanluma is a poly-L-lactic acid implant suitable for increasing the volume of depressed areas, particularly to correct skin depressions.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Lanluma distributor. Alternatively send the details to Sinclair on: quality@sinclair.com

For a full list of contraindications, warnings and precautions for this product please visit https://www.sinclairpharma.com/eifu for copy of the Product Instructions for Use.